FDA Approved: BREO ELLIPTA — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved Breo Ellipta (fluticasone furoate and vilanterol) in its original application. It is an inhaled corticosteroid/long-acting beta-agonist therapy for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BREO ELLIPTA (fluticasone furoate and vilanterol trifenatate)

Snippet

ORIG AP for BREO ELLIPTA (FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE)